Harbour Capital Advisors LLC Invests $405,000 in Astera Labs, Inc. $ALAB

Key Points

• Harbour Capital Advisors LLC acquired 4,575 shares of Astera Labs, Inc. valued at approximately $405,000 during the 2nd quarter.
• Astera Labs reported a 149.5% increase in revenue year-over-year, reaching $191.93 million, with earnings per share (EPS) beating expectations at $0.44.
• Insider sales included CEO Jitendra Mohan selling 152,517 shares for over $25 million, leading to a decrease in his ownership by 25.31%.

Harbour Capital Advisors LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,575 shares of the company's stock, valued at approximately $405,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Oliver Lagore Vanvalin Investment Group bought a new position in shares of Astera Labs during the 2nd quarter worth about $29,000. Wealth Enhancement Advisory Services LLC bought a new position in shares of Astera Labs during the 2nd quarter worth about $431,000. Jackson Square Capital LLC bought a new position in shares of Astera Labs during the 2nd quarter worth about $294,000. GSG Advisors LLC boosted its position in shares of Astera Labs by 16.2% during the 2nd quarter. GSG Advisors LLC now owns 10,506 shares of the company's stock worth $950,000 after purchasing an additional 1,468 shares in the last quarter. Finally, Mirador Capital Partners LP bought a new position in shares of Astera Labs during the 2nd quarter worth about $1,608,000. Institutional investors own 60.47% of the company's stock.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the transaction, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares of the company's stock, valued at $939,453,160.90. This represents a 4.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,576,713 shares of company stock valued at $239,237,016 over the last 90 days. 12.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of research analyst reports. Morgan Stanley increased their price objective on shares of Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday, August 29th. Susquehanna raised their price target on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a research report on Tuesday, September 2nd. Wall Street Zen raised shares of Astera Labs from a "hold" rating to a "buy" rating in a research report on Saturday, August 16th. Finally, Needham & Company LLC raised their price target on shares of Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs has an average rating of "Moderate Buy" and a consensus price target of $152.94.

Astera Labs Trading Down 2.7%

Shares of ALAB stock traded down $6.68 during trading hours on Friday, hitting $245.20. 22,431,313 shares of the company were exchanged, compared to its average volume of 4,617,677. The firm has a fifty day simple moving average of $169.95 and a 200 day simple moving average of $109.80. Astera Labs, Inc. has a 52-week low of $47.00 and a 52-week high of $262.90. The stock has a market capitalization of $40.76 billion, a price-to-earnings ratio of 437.86, a P/E/G ratio of 6.22 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the business posted $0.13 EPS. Astera Labs's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.